EULAR 2020 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceEULAR 2020 1 September, 2020 15:43
Letter from the Editor EULAR 2020 EditorProf. Dennis McGonagle, University of Leeds, UK ConferenceEULAR 2020 28 August, 2020 16:41
COVID-19 and inflammatory rheumatic disease: some key issues Presented ByProf. G. Burmester, Charité University Hospital, Germany ConferenceEULAR 2020 14 August, 2020 15:06
Preliminary findings suggest rozibafusp alfa effective and tolerable in RA ConferenceEULAR 2020 14 August, 2020 09:56
Immune-related AEs due to checkpoint inhibitors require care coordination ConferenceEULAR 2020 14 August, 2020 09:49
New nanoparticle promising future agent in RA Presented ByProf. Kira Astakhova, Technical University of Denmark, Denmark ConferenceEULAR 2020 14 August, 2020 09:43
Olokizumab significantly improves RA features and patient-reported outcomes Presented ByProf. Rumen Stoilov, University Hospital St. Ivan Rilski, Bulgaria TrialCREDO-1 ConferenceEULAR 2020 14 August, 2020 09:33
Low DAS at 4 months predicts sustained DMARD-free remission Presented ByMs Marloes Verstappen, Leiden University Medical Center, the Netherlands ConferenceEULAR 2020 14 August, 2020 07:50
Reduced maintenance dose of certolizumab pegol can be used in axSpA Presented ByProf. Robert Landewé, University of Amsterdam, the Netherlands TrialC-OPTIMISE ConferenceEULAR 2020 14 August, 2020 10:30
Worse response axSpA patients to second TNFi versus first TNFi Presented ByDr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal ConferenceEULAR 2020 14 August, 2020 10:27
AxSpA real-life remission rates higher on biologics Presented ByDr Charlotte Baert, Saint Luc University Hospital, Belgium ConferenceEULAR 2020 14 August, 2020 10:24
Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis Presented ByProf. Irene van der Horst-Bruinsma, Amsterdam University Medical Center, the Netherlands TrialC-VIEW ConferenceEULAR 2020 14 August, 2020 10:19
TNF-α inhibitors improve bone mineral density in AS patients Presented ByMark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands ConferenceEULAR 2020 14 August, 2020 10:13
Ixekizumab shows sustained improvements in pain and fatigue at 3 years Presented ByProf. Ana-Maria Orbai, Johns Hopkins University School of Medicine, USA TrialSPIRIT-P2 ConferenceEULAR 2020 14 August, 2020 14:15
Adalimumab added to methotrexate yields better results in PsA than methotrexate escalatio Presented ByDr Laura Coates, Oxford University, United Kingdom TrialPhase 4, CONTROL ConferenceEULAR 2020 14 August, 2020 14:09
Upadacitinib provides fast onset of improvement in psoriatic arthritis Presented ByProf. Iain McInnes, University of Glasgow, Scotland TrialSELECT-PsA-1 ConferenceEULAR 2020 14 August, 2020 14:02
Secukinumab monotherapy as efficient as adalimumab Presented ByProf. Iain McInnes, University of Glasgow, United Kingdom TrialPhase 3, EXCEED ConferenceEULAR 2020 14 August, 2020 13:11
Higher mortality risk with tramadol versus NSAIDs for osteoarthritis patients Presented ByLingyi Li, University of British Columbia, Canada ConferenceEULAR 2020 14 August, 2020 14:37
Hydroxychloroquine not effective in patients with hand osteoarthritis Presented ByDr Claudia Kedor, Charité – Universitätsmedizin Berlin, Germany TrialOA-TREAT ConferenceEULAR 2020 14 August, 2020 14:34
Positive effect denosumab on fall risk Presented ByDr Yasser El Miedany, Darent Valley Hospital, United Kingdom ConferenceEULAR 2020 14 August, 2020 14:27
Anifrolumab achieves rapid and durable BICLA-response Presented ByProf. Eric Morand, Monash University, Australia TrialTULIP-1, TULIP-2 ConferenceEULAR 2020 14 August, 2020 15:01
Subclinical myocardial involvement progresses in SSc patients Presented ByDr Devis Benfaremo, Università Politecnica delle Marche, Italy ConferenceEULAR 2020 14 August, 2020 14:55
Wide variation in prescription and dosing patterns for hydroxychloroquine in SLE ConferenceEULAR 2020 14 August, 2020 14:52
Composite endpoint CRESS for primary Sjögren’s syndrome Presented ByDr Suzanne Arends, University Medical Center Groningen, the Netherlands ConferenceEULAR 2020 14 August, 2020 14:43
COVID-19 and inflammatory rheumatic disease: some key issues Presented ByProf. G. Burmester, Charité University Hospital, Germany ConferenceEULAR 2020 14 August, 2020 15:06